Rws Share Discussion Threads

[douglas fir] 02/8/2017 17:52

off topic......but co's with similiar outlook on life and how to go about bldg a business....hxxps://www.undercurrentnews.com/2017/08/02/hilton-confirms-deal-talks-for-seachill/

[davr0s] 01/8/2017 11:46

Employee share scheme, divi reinvestment? - could be anything. Just noise/ignore

[linhur] 28/7/2017 00:06

P that's called a signal!!

[phillis] 27/7/2017 08:13

who buys 4 shares?

[broadwood] 26/7/2017 16:49

Broker upgrade maybe?

[phillis] 26/7/2017 16:46

stellar

a lot of small AT buys today

[jeffian] 26/7/2017 16:33

Is Parvez still about? It would be nice to have an intraday chart in the header, or at least a shorter term on which shows movements in more detail.

[phillis] 26/7/2017 12:34

ee bah gum!

[panic investor] 03/7/2017 12:07

Nice chart ready for a breakout

[alter ego] 22/6/2017 16:42

I agree with your plus points Woodcutter. China should assume a greater significance going forward too. The main drawback is the p/e which prices in quite a lot of future growth. It's definitely a hold in my portfolio, having six bagged since 2010 but I can understand why someone with other prospects might be tempted to cash in.

[woodcutter] 22/6/2017 16:12

I see Tempus suggested taking profits on wednesday in the Times.

This is a niche business with very little quality competion so a good moat. I'm inclined to think he's rather preamature. There's a lot more to go yet from the acqusitions yet imv

woody

[woodcutter] 22/6/2017 15:14

Hargreave Hale accumulating



woody

[linhur] 21/6/2017 17:47

Disappointed that no CFO has been appointed since Richard Thompson was appointed CEO. RT will have his hands full monitoring the two acquisitions in the USA. May be that they are testing an internal appointment.

[phillis] 20/6/2017 14:38

IHT relief also
Which is why Mr Brode is holding on...

[walbrock82] 20/6/2017 13:22

The half-year results came in as expected with profits growing thanks to the recent two big acquisitions.

However, if analysts forecast is right for 2017, it means trailing adjusted P/E of 29 times.

In 2018, adjusted EPS rises by 14.4 pence, a 6% increase, giving a 2-year trailing P/E of 27.5 times.

The average P/E in the last 11 years is 18 times with the lows at 8 times, during the financial crisis.
If you want to read my analysis on RWS Holding and why this company is a best-kept secret for so long, then the link is

For those long-term holders, this stock is a hold because of its attractive dividends.

BTW, if you held this stock for 11 years, your yield on costs would have risen from 2.8% to 13.54% and the capital appreciation is equivalent to a 10-bagger!

[microscope] 20/6/2017 09:34

Spectacular. What a chart. Powering ahead and with business outlook strong, superb company. Brode really has the Midas touch! Hope he doesn't lose it, as an LTG holder. Recent profit taking there also a buying opportunity imho.

[phillis] 20/6/2017 08:12

Outstanding

[mikkydhu] 20/6/2017 07:57

Dividend increase: 13%

[broadwood] 20/6/2017 07:47

RWS Holdings said its pretax profit for the first half was £14.3m, up from £10.9m. Revenue was £76.6m, from £56.9m.

The company improved its interim dividend 3% to 1.30p a share, from 1.15p.

"This has been a period of extremely strong performance across all of the Group's service offerings," said chairman Andrew Brode.

"Having completed the integration of CTi, we were delighted to have acquired LUZ, which complements our existing life sciences offering both operationally and geographically.

"As the premier global supplier of intellectual property support services and now a major force in life sciences, we believe we are exceptionally well positioned to drive further international expansion."

Brode said that both RWS' financial and market positions remained strong and that it continued to see an interesting pipeline of niche acquisition opportunities to complement its organic growth.

"Overall, we anticipate further progress in the second half of the financial year, with the full benefit of the LUZ acquisition which is already contributing strongly."

[arcadian] 20/6/2017 07:25

Better than current forecasts. Just look at the momentum, cash flow and net debt after acquisition costs.

[nfs] 20/6/2017 07:14

15p adjusted eps for the full year?

[broadwood] 20/6/2017 07:06

Looking good.

This has been a period of extremely strong performance across all of the Group's service offerings. Having completed the integration of CTi, we were delighted to have acquired LUZ, which complements our existing life sciences offering both operationally and geographically.
"As the premier global supplier of intellectual property support services and now a major force in life sciences, we believe we are exceptionally well positioned to drive further international expansion.
"Both our financial and market positions remain strong and we continue to see an interesting pipeline of niche acquisition opportunities to complement our organic growth.
"Overall, we anticipate further progress in the second half of the financial year, with the full benefit of the LUZ acquisition which is already contributing strongly

[arcadian] 15/6/2017 17:30

They want stock to sell back to us on Tuesday.

[panic investor] 14/6/2017 19:23

Weird price action today